Nitrofurantoin unmasking peripheral neuropathy in a type 2 diabetic patient.
It is well documented that patients with preexisting renal dysfunction are at increased risk of having nitrofurantoin-induced peripheral neuropathy develop. A diabetic patient whose condition was controlled by diet alone had peripheral neuropathy develop four days after starting nitrofurantoin therapy for the treatment of a urinary tract infection.
D000368:Aged; D000855:Anorexia / Q000139:chemically induced; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003929:Diabetic Neuropathies / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009431:Neural Conduction / Q000187:drug effects; D009582:Nitrofurantoin / Q000009:adverse effects*; D010292:Paresthesia / Q000139:chemically induced; D011597:Psychomotor Performance / Q000187:drug effects
D009582:Nitrofurantoin